Makoto Sakai

サカイマコト | Makoto Sakai

Affiliation and department：

Research field (1)： Digestive surgery

Research theme for competitive and other funds (6)：

2022 - 2025 がん細胞特異的アミノ酸トランスポーターを標的とした新規複合的がん免疫療法の開発
2021 - 2024 Development of a innovative combination therapy of hyperthermia and immune checkpoint inhibitors
2020 - 2023 革新的治療ツールを利用した癌微小管ダイナミクス制御による消化管癌の克服を目指して
2018 - 2021 Regulation of radiation sensitivity using ultrafine nanobubble oxygen
2015 - 2018 Potential of tumore suppressor FBXW7 as one of the therapeutic targets

Show all

Papers (409)：

Nobuhiro Nakazawa, Makoto Sohda, Munenori Ide, Yuki Shimoda, Akihiko Sano, Makoto Sakai, Tetsunari Oyama, Ken Shirabe, Hiroshi Saeki. Poorly cohesive gastric cancer with increased epithelial-mesenchymal transition is associated with a poor prognosis. Oncology letters. 2024. 28. 3. 420-420
Makoto Sakai, Makoto Sohda, Shintaro Uchida, Arisa Yamaguchi, Takayoshi Watanabe, Hideyuki Saito, Yasunari Ubukata, Nobuhiro Nakazawa, Kengo Kuriyama, Akihiko Sano, et al. Reply to: "Predictive Role of Age-Adjusted Charlson Comorbidity Index for Long-Term Survival in Surgical Esophageal Cancer Patients," by Yuan, Yong et al. Annals of surgical oncology. 2024. 31. 8. 5101-5101
Natsumi Mori, Gendensuren Dorjkhorloo, Takuya Shiraishi, Bilguun Erkhem-Ochir, Haruka Okami, Arisa Yamaguchi, Ikuma Shioi, Chika Komine, Mizuki Endo, Takaomi Seki, et al. A Mature Tertiary Lymphoid Structure with a Ki-67-Positive Proliferating Germinal Center Is Associated with a Good Prognosis and High Intratumoral Immune Cell Infiltration in Advanced Colorectal Cancer. Cancers. 2024. 16. 15
Nobuhiro Nakazawa, Makoto Sohda, Mizuki Endo, Nobuhiro Hosoi, Shintaro Uchida, Takayoshi Watanabe, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Ken Shirabe, et al. The Gustave Roussy Immune score is a powerful biomarker for predicting therapeutic resistance to chemotherapy in gastric cancer patients. Cancer chemotherapy and pharmacology. 2024
Ikuma Shioi, Hiroomi Ogawa, Ryozan Naito, Mizuki Endo, Nobuhiro Hosoi, Kohei Tateno, Shintaro Uchida, Arisa Yamaguchi, Takayoshi Watanabe, Nobuhiro Nakazawa, et al. Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer. Anticancer research. 2024. 44. 7. 3013-3023

ｍore...

MISC (704)：

山口亜梨紗, 宗田真, 細井信宏, 渡邊隆嘉, 中澤信博, 大曽根勝也, 岡田拓久, 白石卓也, 佐野彰彦, 横堀武彦, et al. 食道扁平上皮癌におけるTIF1γ発現の意義. 日本分子腫瘍マーカー研究会誌. 2024. 39. 12-13
渡邊隆嘉, 宗田真, 中澤信博, 佐野彰彦, 酒井真, 佐伯浩司. 【進行消化器癌に対するconversion surgeryのすべて】食道 cT4食道癌に対する化学放射線療法後の治療戦略. 外科. 2023. 85. 13. 1383-1387
酒井真, 佐伯浩司, 加藤健, 門脇重憲, 笠原佑記, 佐藤雄亮, 三梨桂子, 山本駿, 小柳和夫, 伊澤直樹, et al. 進行・再発食道がん患者の治療体系と予後に関する観察研究(POME). 日本癌治療学会学術集会抄録集. 2023. 61回. O5-4
渡邊隆嘉, 宗田真, 舘野航平, 中澤信博, 酒井真, 佐野彰彦, 小川博臣, 調憲, 佐伯浩司. 当科における切除不能進行・再発食道癌に対する免疫チェックポイント阻害薬の治療成績. 日本癌治療学会学術集会抄録集. 2023. 61回. YOA O6-4
中澤信博, 細井信宏, 渡邊隆嘉, 佐野彰彦, 酒井真, 小川博臣, 関口雅則, 斎藤加奈, 長沼篤, 保坂尚志, et al. GRIm-sは胃癌化学療法や免疫治療の治療抵抗性を予測する強力なバイオマーカーである. 日本癌治療学会学術集会抄録集. 2023. 61回. O28-2

ｍore...

Work history (1)：

Gunma University

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page